Document is current
Any future updates will be listed below
-
Authors
Koukourakis, Ioannis M.
Karpouzis, Antonios
Filippatos, Konstantinos
Mamalis, Panagiotis
Kakagia, Despina
Giatromanolaki, Alexandra
Kouloulias, Vassilis
Zygogianni, Anna
Koukourakis, Michael I. https://orcid.org/0000-0002-2324-699X
-
Funding
Funding for this research was provided by:
Democritus University of Thrace
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 13 May 2025
First Online: 4 June 2025
Declarations
:
: The authors declare no competing interests.
: The study has been approved by the local Scientific and Research Ethics Committee (Approval number ES9 04-5-2022). The study was conducted according to the Declaration of Helsinki and the Guidelines for Good Clinical Practice. Moreover, approval for the administration of cemiplimab has been obtained for each patient separately, following application to the National Organization for the Provision of Health Services (EOΠYY).
: Written informed consent was obtained from all individual participants included in the study.
: All patients gave written informed consent to use and publish anonymously all clinical and laboratory data for educational and research purposes.
